MOTS-c WADA rules explained: the peptide is not named on the Prohibited List, but S0 likely bans it. See how it compares to AOD-9604 and tesamorelin.
MOTS-c is not named on the World Anti-Doping Agency (WADA) Prohibited List, but it is effectively banned in sport. Because no government health authority has approved MOTS-c for human use, the peptide falls under WADA category S0, Non-Approved Substances, which is prohibited at all times, in and out of competition. An athlete who tests positive for MOTS-c faces the same sanctions as one who tests positive for a substance the List names directly.
What Is MOTS-c?
MOTS-c is a 16-amino-acid peptide encoded in the mitochondrial genome rather than the cell nucleus. Researchers first described it in 2015 and have studied it mainly as a regulator of metabolism, insulin sensitivity, and exercise capacity.
Every MOTS-c product sold online is a research chemical. It has no FDA approval, no approved human dose, and no pharmacy-grade quality control.
Questions about mots-c benefits usually focus on metabolic and performance effects, and nearly all of that evidence comes from animal models and cell studies rather than controlled human trials.
Why WADA's S0 Category Captures MOTS-c
WADA's Prohibited List works through categories, not just individual names. S0 prohibits any pharmacological substance that no other category covers and that lacks current approval from a governmental regulatory health authority for human therapeutic use.
MOTS-c meets that definition, which means it is banned at all times.
A few practical points follow from S0:
- S0 substances are prohibited in and out of competition, so there is no off-season window.
- WADA applies strict liability, meaning an athlete is responsible for what is found in their sample regardless of intent.
- Because MOTS-c has no recognized medical use, a therapeutic use exemption is essentially unavailable.
How MOTS-c Compares to Other Peptides Under WADA Rules
| Substance | Approved for human use? | WADA status | Basis |
|---|---|---|---|
| MOTS-c | No | Prohibited at all times | S0 Non-Approved Substances |
| AOD-9604 | No | Prohibited at all times | S0 Non-Approved Substances |
| Tesamorelin | Yes (FDA-approved as Egrifta) | Prohibited | S2 Growth hormone-releasing peptides |
| SS-31 (elamipretide) | No | Prohibited at all times | S0 Non-Approved Substances |
| BPC-157 | No | Prohibited at all times | S0 Non-Approved Substances |
The aod 9604 vs mots-c comparison is mostly a marketing debate: both are unapproved research peptides, and WADA treats both as prohibited under S0.
Running aod 9604 and mots-c together does not change that math. Stacking two unapproved peptides adds unknown risk without creating any exemption.
An ss-31 and mots-c protocol is often pitched as mitochondrial support, and the same S0 reasoning applies to both peptides.
Websites that publish an aod 9604 mots-c tesamorelin dosage chart are describing amounts that no regulator has approved for human use.
Can WADA Labs Actually Detect MOTS-c?
WADA-accredited laboratories screen for peptides with mass spectrometry, and their methods are updated as new compounds appear on the market. A published, validated test for MOTS-c may not exist today, but that offers athletes no protection.
Samples can be stored and reanalyzed for years, and anti-doping rules allow sanctions based on non-analytical evidence such as shipping records, documents, or admissions.
The absence of a routine test is not a loophole; it is a delay.
What Athletes Should Do
- Search the substance on Global DRO or contact USADA before using any peptide or supplement.
- Assume that any product labeled "research use only" or "not for human consumption" is prohibited under S0.
- Ask a licensed healthcare professional about approved options for the condition you are trying to address.
- Keep records of everything you take, including third-party certificates of analysis for supplements.
MOTS-c is not an approved treatment for any medical condition in the United States.
Safety Questions Beyond Anti-Doping
Anti-doping status is only one concern. Human safety data for MOTS-c is thin, and research peptides sold online are frequently mislabeled, underdosed, or contaminated.
- Injection-site reactions and immune responses are possible with any injectable research peptide.
- Because MOTS-c influences metabolism, its effects on blood sugar and insulin signaling are not fully understood.
- Long-term effects of repeated use in humans have not been established.
Anyone considering a research peptide should discuss it with a healthcare professional instead of relying on vendor claims or forum posts.
The Bottom Line for Athletes
MOTS-c does not need to appear by name on the WADA Prohibited List to be banned. The S0 catch-all covers unapproved substances, and MOTS-c has no approval for human use anywhere in the world.
MOTS-c is prohibited at all times for athletes subject to WADA rules. Switching to a different research peptide, lowering the dose, or stacking with AOD-9604 or SS-31 does not remove the risk of a positive test.
Frequently Asked Questions
Is MOTS-c banned by WADA?
Yes, in practice. MOTS-c is not named on the WADA Prohibited List, but it is prohibited at all times under category S0, Non-Approved Substances, because no government regulator has approved it for human use. Athletes who test positive for it face standard anti-doping sanctions.
Is AOD-9604 on the WADA banned list?
AOD-9604 is not listed by name either, but it is treated as prohibited under S0 for the same reason as MOTS-c: it has no approval for human therapeutic use. Anti-doping authorities have applied that reasoning to AOD-9604 for years, so athletes should treat it as banned.
Can athletes get a TUE for MOTS-c?
Generally no. A therapeutic use exemption requires a legitimate, approved medical use, and MOTS-c has no regulatory approval for treating any condition. Athletes should confirm current rules with USADA or WADA before using any peptide.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.